UNITED THERAPEUTICS Corp Quarterly Other Assets, Noncurrent in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
UNITED THERAPEUTICS Corp quarterly Other Assets, Noncurrent history and growth rate from Q2 2010 to Q2 2024.
  • UNITED THERAPEUTICS Corp Other Assets, Noncurrent for the quarter ending June 30, 2024 was $168M, a 24.1% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $168M +$32.6M +24.1% Jun 30, 2024 10-Q 2024-07-31
Q1 2024 $169M +$44.6M +35.8% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $152M +$37.5M +32.8% Dec 31, 2023 10-Q 2024-07-31
Q3 2023 $142M +$26.9M +23.4% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $135M +$29.5M +27.9% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $125M +$11.2M +9.89% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $114M +$6.1M +5.64% Dec 31, 2022 10-K 2024-02-21
Q3 2022 $115M +$5.8M +5.32% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $106M -$71.2M -40.2% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $113M -$57.9M -33.8% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $108M -$61.7M -36.3% Dec 31, 2021 10-K 2023-02-22
Q3 2021 $109M -$56.4M -34.1% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $177M +$9.6M +5.74% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $171M +$3.2M +1.91% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $170M +$15.3M +9.9% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $165M -$65.6M -28.4% Sep 30, 2020 10-Q 2020-10-28
Q2 2020 $167M -$35.5M -17.5% Jun 30, 2020 10-Q 2020-07-29
Q1 2020 $168M -$67.4M -28.6% Mar 31, 2020 10-Q 2020-04-29
Q4 2019 $155M -$69.6M -31% Dec 31, 2019 10-K 2021-02-24
Q3 2019 $231M -$30.7M -11.7% Sep 30, 2019 10-Q 2019-10-30
Q2 2019 $203M -$54.4M -21.1% Jun 30, 2019 10-Q 2019-07-31
Q1 2019 $235M +$100K +0.04% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 $224M +$100K +0.05% Dec 31, 2018 10-K 2020-02-26
Q3 2018 $262M +$48.7M +22.9% Sep 30, 2018 10-Q 2018-10-31
Q2 2018 $257M +$71.4M +38.4% Jun 30, 2018 10-Q 2018-08-01
Q1 2018 $235M +$31.2M +15.3% Mar 31, 2018 10-Q 2018-05-02
Q4 2017 $224M +$27M +13.7% Dec 31, 2017 10-K 2019-02-27
Q3 2017 $213M +$43.3M +25.5% Sep 30, 2017 10-Q 2017-10-25
Q2 2017 $186M +$16.5M +9.74% Jun 30, 2017 10-Q 2017-07-27
Q1 2017 $204M +$44.3M +27.7% Mar 31, 2017 10-Q 2017-04-26
Q4 2016 $197M +$42.9M +27.8% Dec 31, 2016 10-K 2018-02-21
Q3 2016 $170M +$16.6M +10.8% Sep 30, 2016 10-Q 2016-10-27
Q2 2016 $169M +$66.5M +64.6% Jun 30, 2016 10-Q 2016-07-28
Q1 2016 $160M +$62.3M +63.9% Mar 31, 2016 10-Q 2016-04-28
Q4 2015 $154M +$56.3M +57.4% Dec 31, 2015 10-K 2017-02-22
Q3 2015 $153M +$54.7M +55.6% Sep 30, 2015 10-Q 2015-10-27
Q2 2015 $103M -$769K -0.74% Jun 30, 2015 10-Q 2015-07-28
Q1 2015 $97.5M +$44.4M +83.7% Mar 31, 2015 10-Q 2015-04-28
Q4 2014 $97.9M +$44.7M +83.9% Dec 31, 2014 10-K 2016-02-25
Q3 2014 $98.4M +$45M +84.2% Sep 30, 2014 10-Q 2014-10-28
Q2 2014 $104M +$45.7M +78.9% Jun 30, 2014 10-Q 2014-07-29
Q1 2014 $53.1M +$26.5M +99.6% Mar 31, 2014 10-Q 2014-04-29
Q4 2013 $53.3M +$26.5M +98.9% Dec 31, 2013 10-K 2015-02-24
Q3 2013 $53.4M +$25.3M +90.3% Sep 30, 2013 10-Q 2013-10-29
Q2 2013 $58M +$29.8M +106% Jun 30, 2013 10-Q 2013-07-25
Q1 2013 $26.6M -$1.45M -5.18% Mar 31, 2013 10-Q 2013-04-25
Q4 2012 $26.8M -$942K -3.4% Dec 31, 2012 10-K 2014-02-25
Q3 2012 $28.1M +$5.9M +26.6% Sep 30, 2012 10-Q 2012-11-01
Q2 2012 $28.1M +$7.05M +33.5% Jun 30, 2012 10-Q 2012-07-26
Q1 2012 $28.1M +$7.15M +34.2% Mar 31, 2012 10-Q 2012-04-26
Q4 2011 $27.7M +$16.6M +149% Dec 31, 2011 10-K 2013-02-26
Q3 2011 $22.2M +$14M +173% Sep 30, 2011 10-Q 2011-10-27
Q2 2011 $21.1M +$13.3M +170% Jun 30, 2011 10-Q 2011-07-28
Q1 2011 $20.9M Mar 31, 2011 10-Q 2011-04-28
Q4 2010 $11.1M Dec 31, 2010 10-K 2012-02-28
Q3 2010 $8.14M Sep 30, 2010 10-Q 2010-10-28
Q2 2010 $7.81M Jun 30, 2010 10-Q 2010-07-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.